Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights

Go back to Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights
(NASDAQ: TRAW) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High
Open $0.60    52 Week Low
Day High $0.60    P/E N/A 
Day Low $0.60    EPS
Volume 105